1. |
卫生部统计信息中心. 2013中国卫生统计年鉴. 2014-04-26. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index-2013.html.
|
2. |
邹小农, 孙喜斌, 陈万青, 等. 2003-2007年中国胃癌发病与死亡情况分析. 肿瘤, 2012, 32(2):109-114.
|
3. |
邹文斌, 李兆申. 中国胃癌发病率及死亡率研究进展. 中国实用内科杂志, 2014, 34(4):408-415.
|
4. |
段纪俊, 陈万青, 张思维. 中国恶性肿瘤死亡率的国际比较. 中国社会医学杂志, 2009, 26(6):377-378.
|
5. |
Schneider T, Ehrig K, Liewert I, et al. Interference with the CXCL12/CXCR4 axis as potential antitumor strategy:superiority of a sulfated galactofucan from the brown alga Saccharina latissima and Fucoidan over heparins. Glycobiology, 2015, 25(8):812-824.
|
6. |
Oishi S, Kuroyanagi T, Kubo T, et al. Development of novel CXC chemokine receptor 7 (CXCR7) ligands:selectivity Switch from CXCR4 antagonists with a cyclic pentapeptide scaffold. J Med Chem, 2015, 58(13):5218-5225.
|
7. |
Guillemot E, Karimdjee-Soilihi B, Pradelli E, et al. CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver. Br J Cancer, 2012, 107(12):1944-1949.
|
8. |
Monnier J, Boissan M, L'Helgoualc'h A, et al. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer, 2012, 48(1):138-148.
|
9. |
Lapteva N, Yang AG, Sanders DE, et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther, 2005, 12(1):84-89.
|
10. |
Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer:a possible role for tumor progression. Clin Cancer Res, 2000, 6(9):3530-3535.
|
11. |
Edge SB, Compton CC. The American joint committee on cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6):1471-1474.
|
12. |
Yamaguchi R, Yano H, Nakashima O, et al. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol, 2006, 21(1 Pt 1):152-160.
|
13. |
Strieter RM, Burdick MD, Gomperts BN, et al. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev, 2005, 16(6):593-609.
|
14. |
Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemo-kines and their receptors in cancer. Cancer Lett, 2008, 267(2):226-244.
|
15. |
Balkwill FR. The chemokine system and cancer. J Pathol, 2012, 226(2):148-157.
|
16. |
Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res, 2014, 124:31-82.
|
17. |
Bonavia R, Bajetto A, Barbero S, et al. Chemokines and their recep-tors in the CNS:expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett, 2003, 139(2-3):181-189.
|
18. |
徐萌, 陈新明. 趋化因子及其受体在口腔鳞癌侵袭和转移中的作用. 国外医学:口腔医学分册, 2005, 32(3):204-206.
|
19. |
Müller A, Homey B, Soto H, et al. Involvement of chemokine recep-tors in breast cancer metastasis. Nature, 2001, 410(6824):50-56.
|
20. |
魏梅, 梁立治, 张昌卿, 等. 宫颈腺癌细胞CXCR4/CXCL12过表达与淋巴结转移和慢性炎症的关系. 癌症, 2007, 26(3):298-302.
|
21. |
Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem, 2005, 280(42):35760-35766.
|
22. |
Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med, 2006, 203(9):2201-2213.
|
23. |
Luker KE, Gupta M, Steele JM, et al. Imaging ligand-dependent activation of CXCR7. Neoplasia, 2009, 11(10):1022-1035.
|
24. |
Meijer J, Ogink J, Roos E. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo. Br J Cancer, 2008, 99(9):1493-1501.
|
25. |
Iwakiri S, Mino N, Takahashi T, et al. Higher expression of chemo-kine receptor CXCR7 is linked to early and metastatic recurrence in pathological stageⅠnonsmall cell lung cancer. Cancer, 2009, 115 (11):2580-2593.
|
26. |
Hao M, Zheng J, Hou K, et al. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol, 2012, 84(2):204-214.
|
27. |
Satomura H, Sasaki K, Nakajima M, et al. Can expression of CXCL12 and CXCR4 be used to predict survival of gastric cancer patients?. Anticancer Res, 2014, 34(8):4051-4057.
|
28. |
Nikzaban M, Hakhamaneshi MS, Fakhari S, et al. The chemokine receptor CXCR4 is associated with the staging of gastric cancer. Adv Biomed Res, 2014, 3(1):16.
|
29. |
Kwak MK, Hur K, Park DJ, et al. Expression of chemokine receptors in human gastric cancer. Tumour Biol, 2005, 26(2):65-70.
|
30. |
Masuda T, Nakashima Y, Ando K, et al. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer. Anticancer Res, 2014, 34(11):6397-6403.
|
31. |
许统俭, 符炜, 徐为, 等. CXCR7与VEGF在胃癌组织中的表达及临床意义. 江苏医药, 2013, 39(13):1534-1536.
|
32. |
师阿盟, 董蕾, 史海涛, 等. 趋化因子受体7在胃癌组织及细胞中的表达及意义. 南方医科大学学报, 2014, 34(12):1780-1784.
|